- Investigator
- Michael J Haller
- Status
- Accepting Candidates
About me
Hello! My name is Dr. Haller but my patients call me Dr. Mike. I work as a Professor and Chief of Pediatric Endocrinology at the University of Florida. As a Gainesville native, and the child of two teachers, I was exposed from an early age to the many incredible educational opportunities afforded by our diverse and highly educated city. My early interests in biology and chemistry combined with my desire to help people and work with children led me pretty directly towards pursuing a career in pediatrics. My interest in pediatric endocrinology was shaped by my grandfather’s experience living with diabetes, experiences volunteering at the Florida Diabetes Camps, and exceptional mentoring from Drs. Desmond Schatz, Janet Silverstein and Mark Atkinson.
I have been involved in type 1 diabetes research since the early 1990s and have published over 200 manuscripts and more than 20 reviews/book chapters on type 1 diabetes pathogenesis, prevention, and interdiction. I am the principal investigator or co-investigator on numerous JDRF, NIH, and Helmsley trust funded studies. My goal is to work every day to improve the lives of children and families affected by type 1 diabetes. I am hopeful that during my career we will develop therapies that can meaningfully prevent and reverse type 1 diabetes.
In my free time, I enjoy spending time with my wife, Dr. Allison Haller (an Anesthesiologist and also a Gator Med School Grad), our 2 children, and our dogs. I also love to spend time in nature, watch live music, attend Gator sporting events, and fly planes.
Accepted insurances
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesMy locations
Active clinical trials
This is a randomized, parallel group, double-blind Phase 2 study with a 52-week blinded extension evaluating the safety and efficacy of 3 dose levels of frexalimab in comparison with placebo in participants with newly diagnosed T1D on insulin…
- Investigator
- Michael J Haller
- Status
- Accepting Candidates
- Ages
- 12 Years - 35 Years
- Sexes
- All
A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes within 100 days of diagnosis.
- Investigators
- Laura Jacobsen, Michael J Haller
- Status
- Accepting Candidates
- Ages
- 12 Years - 35 Years
- Sexes
- All
My research
Top areas of exploration
- Diabetes Mellitus, Type 1 , 66 publications
- Glycated Hemoglobin , 15 publications
- Insulin , 15 publications
- Blood Glucose , 14 publications
Research activity
My areas of focus
Stories and news
UF Health-led guidelines call for widespread Type 1 diabetes screening in children
January 29, 2025
GAINESVILLE, Fla. — A University of Florida Health physician-scientist led an international team of Type 1 diabetes experts who recently developed new…
Department of Pediatrics, +4 more
UF Health Shands Children’s Hospital is ranked No. 1 in Florida, five specialties among nation’s best
June 14, 2022
Related video: UF Health Shands Children’s Hospital ranked No. 1 in Florida University of Florida Health Shands Children’s Hospital continued its remarkable…
College of Medicine, UF Health Shands Children's Hospital, +2 more